Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDAY
2001
USA Today Co
TDAY
$1.01B
| $9.96M | ﹤0.01% |
1,561,922
+816,966
| +110% | +$5.99M |
|
|
SINA
2002
DELISTED
Sina Corp
SINA
| $9.89M | ﹤0.01% |
248,965
+17,406
| +8% | +$668K |
|
2003
Nice
NICE
$5.78B
| $9.88M | ﹤0.01% |
63,696
+9,457
| +17% | +$1.44M |
|
|
AEGN
2004
DELISTED
Aegion Corp
AEGN
| $9.84M | ﹤0.01% |
439,972
+8,283
| +2% | +$179K |
|
|
DERM
2005
DELISTED
Dermira, Inc.
DERM
| $9.82M | ﹤0.01% |
647,703
+9,334
| +1% | +$80.6K |
|
|
CMO
2006
DELISTED
Capstead Mortgage Corp.
CMO
| $9.81M | ﹤0.01% |
1,238,891
+41,796
| +3% | +$323K |
|
|
FLXN
2007
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $9.8M | ﹤0.01% |
473,517
+34,020
| +8% | +$574K |
|
2008
Banc of California
BANC
$3.1B
| $9.8M | ﹤0.01% |
570,319
+16,459
| +3% | +$249K |
|
|
HTBK
2009
DELISTED
Heritage Commerce
HTBK
| $9.8M | ﹤0.01% |
763,700
+217,626
| +40% | +$2.65M |
|
|
PFC
2010
DELISTED
Premier Financial Corp. Common Stock
PFC
| $9.79M | ﹤0.01% |
311,088
+14,999
| +5% | +$452K |
|
|
QUOT
2011
DELISTED
Quotient Technology Inc
QUOT
| $9.78M | ﹤0.01% |
992,291
-32,644
| -3% | -$313K |
|
2012
Imperial Oil
IMO
$63.1B
| $9.78M | ﹤0.01% |
371,517
+42,041
| +13% | +$1.06M |
|
2013
The Bancorp
TBBK
$2.83B
| $9.76M | ﹤0.01% |
752,598
-1,333
| -0.2% | -$14.9K |
|
2014
Amphastar Pharmaceuticals
AMPH
$850M
| $9.74M | ﹤0.01% |
504,828
+12,807
| +3% | +$246K |
|
2015
Gorman-Rupp
GRC
$2.15B
| $9.74M | ﹤0.01% |
259,689
-2,261
| -0.9% | -$82.3K |
|
|
RVI
2016
DELISTED
Retail Value Inc. Common Shares
RVI
| $9.73M | ﹤0.01% |
2,879,656
+12,965
| +0.5% | +$43.4K |
|
2017
Camden National
CAC
$990M
| $9.72M | ﹤0.01% |
211,159
+4,285
| +2% | +$189K |
|
2018
Schneider National
SNDR
$6.27B
| $9.72M | ﹤0.01% |
445,619
+56,227
| +14% | +$1.27M |
|
2019
QuinStreet
QNST
$1.19B
| $9.72M | ﹤0.01% |
635,018
+61,785
| +11% | +$881K |
|
|
VAL
2020
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $9.72M | ﹤0.01% |
1,481,180
+19,607
| +1% | +$95.5K |
|
|
IPHS
2021
DELISTED
Innophos Holdings, Inc.
IPHS
| $9.71M | ﹤0.01% |
303,765
+15,336
| +5% | +$493K |
|
2022
Genesco
GCO
$391M
| $9.69M | ﹤0.01% |
202,215
-19,848
| -9% | -$823K |
|
|
GLUU
2023
DELISTED
Glu Mobile Inc.
GLUU
| $9.68M | ﹤0.01% |
1,600,421
-398,443
| -20% | -$2.28M |
|
|
EGRX
2024
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9.68M | ﹤0.01% |
161,117
+2,127
| +1% | +$127K |
|
|
NWLI
2025
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $9.65M | ﹤0.01% |
33,189
+1,708
| +5% | +$458K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.